Tirzepatide 30mg: Product Details, Quality and Ordering
Tirzepatide has become an important research compound because it combines activity at two incretin receptors in one synthetic peptide. For laboratories, however, the useful question is not only what tirzepatide does in published pharmaceutical research. It is also whether the research material being considered is clearly identified, documented, and matched to the specifications on the product page.
At Peptide King, our Tirzepatide 30mg is listed as a research-grade lyophilized powder for in-vitro laboratory use only. The page identifies a 30mg nominal quantity, ≥98% HPLC-verified purity, a molecular weight of 4813.45 g/mol, and a length of 39 amino acids.
This guide explains what tirzepatide is, why its dual-receptor profile matters, and what researchers should verify before relying on any tirzepatide research product.
What Is Tirzepatide?
Tirzepatide is a synthetic 39-amino-acid peptide engineered to activate the glucose-dependent insulinotropic polypeptide, or GIP, receptor and the glucagon-like peptide-1, or GLP-1, receptor.
Why Dual GIP and GLP-1 Activity Matters
GIP and GLP-1 are incretin hormones involved in post-meal metabolic signaling. Both interact with receptors found on pancreatic beta cells and in other tissues.
By combining activity at both receptors, tirzepatide became an important molecule for studying multi-incretin signaling rather than one receptor pathway at a time. Published reviews describe tirzepatide as a dual GIP/GLP-1 receptor agonist and a synthetic 39-amino-acid peptide.
Clinical Tirzepatide and Research Material Are Different Products
Tirzepatide is also the active ingredient in authorized prescription medicines. That does not mean independently supplied research-grade tirzepatide is interchangeable with a finished pharmaceutical product.
Clinical trial results apply to the pharmaceutical formulations, manufacturing systems, and protocols used in those studies. We therefore do not transfer clinical efficacy or safety claims onto our research material.
What Does the Tirzepatide 30mg Product Page Specify?
Our current product listing provides several technical specifications that researchers can compare with their project requirements.
The Listed Quantity Is 30mg
The page identifies a nominal quantity of 30mg.
Nominal quantity is the amount stated for the product. It should be distinguished from measured peptide content reported by an analytical laboratory.
The Material Is Supplied as Lyophilized Powder
Lyophilization removes water from a frozen sample under reduced pressure, producing a dry material.
The Tirzepatide 30mg research product is listed in lyophilized form with storage at -20°C protected from light.
The page does not provide human-use, injection, or dosing instructions because the material is intended only for laboratory research.
What Does HPLC-Verified Purity Mean?
Peptide King currently lists the Tirzepatide 30mg product at ≥98% HPLC-verified purity.
HPLC Measures Chromatographic Purity
High-performance liquid chromatography separates components in a sample based on how they interact with a chromatographic system.
For peptide analysis, HPLC can show the relative area of the principal peptide peak compared with other detected components. That produces a chromatographic purity estimate.
Identity Testing Answers a Different Question
A peptide can show a strong main HPLC peak while still requiring separate identity confirmation.
Mass spectrometry is often used to support peptide identity because it provides molecular-mass information that can be compared with the expected compound.
For tirzepatide, published literature describes a synthetic 39-amino-acid peptide with a molecular weight around 4813.45 g/mol.
Purity and identity should therefore be reviewed separately.
Why Lot and Certificate Matching Matters
A Certificate of Analysis is most useful when it can be connected to the exact inventory being considered.
Check More Than the Product Name
When reviewing a CoA, we recommend checking:
- compound name
- lot or batch identifier
- nominal quantity
- measured quantity, if reported
- HPLC purity
- identity testing
- analytical method
- test date
A certificate from a different lot may provide background information, but it does not automatically document the current vial.
Researchers should also record the date they accessed the product page and certificate online, because supplier documentation can change when new inventory, testing, or updated lots become available.
Keep Purity, Identity, and Quantity Separate
A useful research record should distinguish what the supplier states from what the analytical laboratory measured.
What Makes Tirzepatide Different From Retatrutide?
Tirzepatide and retatrutide are often discussed together because both belong to multi-receptor metabolic peptide research.
Tirzepatide Is a Dual Agonist
Tirzepatide targets GIP and GLP-1 receptors.
Peptide King also lists Retatrutide 10mg, which is associated with research into GIP, GLP-1, and glucagon receptor activity.
That third receptor target makes retatrutide a different investigational molecule. The two compounds should not be treated as interchangeable.
What Should Researchers Verify Before Ordering Tirzepatide?
The product title is only the beginning of the procurement decision.
Use a Practical Research Checklist
| Detail | What to verify |
|---|---|
| Identity | Does the documentation correspond to tirzepatide? |
| Quantity | Does the listed amount match the project requirement? |
| Form | Is the material supplied in the expected physical state? |
| Purity | Is the analytical method identified? |
| Lot | Can current documentation be linked to inventory? |
| Storage | Are handling conditions clearly stated? |
| Fulfillment | Is the shipping path suitable for the laboratory? |
How Does Canadian Fulfillment Work?
Peptide King currently ships within Canada and lists domestic order processing information on the site.
Orders Are Fulfilled From Canada
According to the current site, orders are generally processed within one to two business days, with standard delivery estimated at three to seven business days depending on province. Tracking is provided after dispatch.
What Is the Regulatory Context in Canada?
Tirzepatide Is Regulated as a Prescription Drug
Health Canada identifies tirzepatide among injectable peptides regulated as prescription drugs in Canada. The agency also warns that labeling a product “For Research Use Only” does not automatically make it exempt from regulatory requirements.
Peptide King states that its research materials are not intended for human or animal consumption and are not sold as medical treatments.
Researchers should confirm that planned procurement and use comply with applicable laws, licences, ethics approvals, and institutional requirements.
How We Present Tirzepatide Research Material at Peptide King
At Peptide King, we think tirzepatide research products should be evaluated through documentation, not medical claims.
Our Tirzepatide 30mg page provides the compound name, nominal quantity, lyophilized format, stated HPLC purity, molecular weight, amino-acid length, storage information, and research-use limitations.
Understand the molecule. Confirm the receptor profile. Review the lot information. Separate identity, purity, and quantity. Then decide whether the material fits the requirements of the laboratory project.
That is the standard we think matters most when comparing tirzepatide research products.